[The Heart Institute of Japan--candesartan randomized trial for evaluation in CAD (HUJ-CREATE)].
Department of Cardiology, Tokyo Women's Medical University.
Nobuhisa
N
Hagiwara
Hiroshi
H
Ogawa
Hiroshi
H
Kasanuki
D000368:Aged; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000627:therapeutic use*; D001713:Biphenyl Compounds; D003324:Coronary Artery Disease / Q000188:drug therapy*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications*; D008297:Male; D013777:Tetrazoles / Q000627:therapeutic use*
D047228:Angiotensin II Type 1 Receptor Blockers; D001562:Benzimidazoles; D001713:Biphenyl Compounds; D013777:Tetrazoles; C081643:candesartan